Attributes | Values |
---|
rdf:type
| |
Description
| - Due to their reactivating effects, both newly developed K oximes can be considered to be promising oximes for the antidotal treatment of acute tabun poisonings while the oxime HI-6 is still the most promising oxime for the treatment of acute cyclosarin poisonings due to its high potency to reactivate cyclosarin-inhibited acetylcholinesterase in the peripheral as well as central compartment.
- Due to their reactivating effects, both newly developed K oximes can be considered to be promising oximes for the antidotal treatment of acute tabun poisonings while the oxime HI-6 is still the most promising oxime for the treatment of acute cyclosarin poisonings due to its high potency to reactivate cyclosarin-inhibited acetylcholinesterase in the peripheral as well as central compartment. (en)
- Díky reaktivačnímu účinku mohou být K oximy považovány za slibné oximy pro antidotní terapii akutní otravy tabunem, zatímco oxim HI-6 je stále nejslibnějším oximem pro terapii akutní atravy cyklosarinem díky vysoké schopnosti reaktivovat cyklosarinem inhibovanou acetylcholinesterázu v periferním i centrálním kompártmentu. (cs)
|
Title
| - A comparison of reactivating efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) in cyclosarin- and tabun-poisoned rats
- A comparison of reactivating efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) in cyclosarin- and tabun-poisoned rats (en)
- Srovnání reaktivační účinnosti nově vyvinutých oximů (K074, K075) a v současnosti dostupných oximů (obidoxim, HI-6) na cyklosarinem a tabunem otrávených potkanech (cs)
|
skos:prefLabel
| - A comparison of reactivating efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) in cyclosarin- and tabun-poisoned rats
- A comparison of reactivating efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) in cyclosarin- and tabun-poisoned rats (en)
- Srovnání reaktivační účinnosti nově vyvinutých oximů (K074, K075) a v současnosti dostupných oximů (obidoxim, HI-6) na cyklosarinem a tabunem otrávených potkanech (cs)
|
skos:notation
| - RIV/60162694:G44__/07:00001753!RIV08-MO0-G44_____
|
http://linked.open.../vavai/riv/strany
| |
http://linked.open...avai/riv/aktivita
| |
http://linked.open...avai/riv/aktivity
| |
http://linked.open...iv/cisloPeriodika
| |
http://linked.open...vai/riv/dodaniDat
| |
http://linked.open...aciTvurceVysledku
| |
http://linked.open.../riv/druhVysledku
| |
http://linked.open...iv/duvernostUdaju
| |
http://linked.open...titaPredkladatele
| |
http://linked.open...dnocenehoVysledku
| |
http://linked.open...ai/riv/idVysledku
| - RIV/60162694:G44__/07:00001753
|
http://linked.open...riv/jazykVysledku
| |
http://linked.open.../riv/klicovaSlova
| - tabun; cyclosarin; acetylcholinesterase; reactivation; oximes; rat; inhibition (en)
|
http://linked.open.../riv/klicoveSlovo
| |
http://linked.open...odStatuVydavatele
| - GB - Spojené království Velké Británie a Severního Irska
|
http://linked.open...ontrolniKodProRIV
| |
http://linked.open...i/riv/nazevZdroje
| - Journal of Enzyme Inhibition and Medicinal Chemistry
|
http://linked.open...in/vavai/riv/obor
| |
http://linked.open...ichTvurcuVysledku
| |
http://linked.open...cetTvurcuVysledku
| |
http://linked.open...UplatneniVysledku
| |
http://linked.open...v/svazekPeriodika
| |
http://linked.open...iv/tvurceVysledku
| - Kassa, Jiří
- Kuča, Kamil
- Jun, Daniel
|
http://linked.open...n/vavai/riv/zamer
| |
issn
| |
number of pages
| |
http://localhost/t...ganizacniJednotka
| |